Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH).
Clinical trial NCT03338998 · COMPLETED
Trial details
- NCT number
- NCT03338998
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-24
- Primary completion
- 2020-05-13
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.